While acetylcholinesterase inhibitors like donepezil and excitatory amino acid receptor antagonists such as memantine remain the preferred treatment options for AD, it is worth noting that they have been approved by the U.S. Food and Drug Administration (FDA) for multiple decades and offer only partial relief of symptoms.16, 17. Here, ACHE is linked to Alzheimer disease.